55
Views
8
CrossRef citations to date
0
Altmetric
I. PROGRESS IN SECOND GENERATION OLIGOMER THERAPEUTICS

Duplex Stability of Oligonucleotides Containing 7-Substituted 7-Deaza- and 8-Aza-7-Deazapurine Nucleosides

, &
Pages 963-966 | Published online: 16 Aug 2006
 

Abstract

The synthesis of 7-substituted 7-deaza- and 8-aza-7-deazapurine 2′-deoxyribonucleosides, their incorporation into oligonucleotides, and the stability of corresponding duplexes is described.

Notes

5a: 1H-NMR (d6-DMSO): δ, 2.30 (1H, m, H-2′), 2.84 (1H, m, H-2′), 3.06 (2H, m, 2H-5′), 3.76, 3.78 (6H,2s, NMe2), 3.71, 3.72 (6H, 2s, 2 OMe), 3.95 (1H, m, H-4′), 4.51 (1H, m, H-3′), 5.30 (1H, d, 3′-OH), 6.58 (1H, t, H-1′), 6.76–7.37 (13H, m, arom. H), 8.47 (1H, s, H-6), 8.98 (1H, s, CH)

1H-NMR (d6-DMSO): δ, 1.74 (ZH, m, CH2), 2.23 (1H, m, H-2′), 2.46 - 2.48 (3H, m, CH2, H-2′), 3.11, 3.15 (6H, 2s, NMe2), 3.13 (2H, m, 2H-5′), 3.33 (2H, m, CH2), 3.74 (6H, s, OCH3), 3.91 (1H, m, H-4′), 4.34 (1H, m, H-3′), 5.29 (1H, d, 3′-OH), 6.54 (1H, t, H-1′), 6.82–7.36 (13H, m, arom. H), 7.56 (1H, s, H-6), 8.29 (1H, s, H-2), 8.73 (1H, s, CH), 9.43 (1H, s, NH)

1H-NMR (d6-DMSO): δ, 1.12 (6H, m, 2 Me), 1.74 (2H, m, CH2), 2.23 (1H, m, H-2′), 2.41 (2H, m, CH2), 2.76 (1H, m, CH), 3.11 (2H, m, 2H-5′), 3.30 (2H, m, CH2), 3.72 (6H, s, 2 OCH3), 3.90 (1H, m, H-4′), 4.32 (1H, m, H-3′), 5.27 (1H, d, 3′-OH), 6.39 (1H, t, H-1′), 6.85–7.37 (14H, m, arom.H, H-6), 9.47 (1H, t, NHCOCF3), 11,53 (1H, s, NH), 11.81 (1H; s, NH).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.